Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 18 Lymphoma, Non-Hodgkin 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Hodgkin Disease 11 Lymphoma, Large B-Cell, Diffuse 9 Central Nervous System Neoplasms 9 Leukemia, Myeloid, Acute 8 Neuroblastoma 7 Multiple Myeloma 7 Leukemia 7 Brain Neoplasms 7 Small Cell Lung Carcinoma 6 Sarcoma 6 Lymphoma, Large-Cell, Immunoblastic 6 Lymphoma, Mantle-Cell 5 Lymphoma, Follicular 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Lymphoma, B-Cell, Marginal Zone 4 Carcinoma, Non-Small-Cell Lung 4 Burkitt Lymphoma 4 Testicular Neoplasms 3 Teratoma 3 Rhabdoid Tumor 3 Medulloblastoma 3 Lung Neoplasms 3 Astrocytoma 3 Waldenstrom Macroglobulinemia 2 Testicular Germ Cell Tumor 2 Rhabdomyosarcoma 2 Recurrence 2

Interventions

Cyclophosphamide 12 Whole-Body Irradiation 10 fludarabine phosphate 9 Rituximab 9 Peripheral Blood Stem Cell Transplantation 9 Cyclosporine 9 Mycophenolic Acid 7 Filgrastim 7 Etoposide 6 Dexamethasone 6 Busulfan 6 Methotrexate 5 Tacrolimus 4 Carboplatin 4 Bortezomib 4 Vorinostat 3 Thiotepa 3 Radiotherapy 3 Lenalidomide 3 Irinotecan 3 Cytarabine 3 Calcium Dobesilate 3 merphos 2 liposomal amphotericin B 2 laromustine 2 ixabepilone 2 entinostat 2 Transplantation 2 Therapeutics 2 Prednisone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Intraocular Lymphoma × etoposide phosphate × Clear all

NCT00074178 2017-04-21

Protocol-B

OHSU Knight Cancer Institute

Phase 2 Completed

Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡